Bringing Hope To Angolan Children: Mass Health Campaign Begins To Help 3.5 Million

The government of Angola, and its
partners in the Measles Initiative, the Global Fund on AIDS, Tuberculosis
and Malaria, and the U.S. President's Malaria Initiative are launching a
major health campaign to provide life-saving interventions for Angolan
children. The integrated campaign is targeting more than 3.5 million
children with measles and polio vaccinations, vitamin A, de-worming
medication, and, in seven provinces, long-lasting insecticide treated nets
(LLIN's). The campaign begins on July 12 in Luanda, with an official launch
event on July 13 in Mbaza Congo.


This campaign is a follow-up to a previous measles campaign in 2003,
which reached 96 percent of the targeted group. The current campaign
demonstrates the importance of follow-up immunization activities in a
country where only 64 percent of children receive routine measles
immunizations. As a part of the Angolan government's Maternal and Child
Health Mortality Reduction Program, the campaign will focus on vulnerable
children, especially those in border regions where there has been a
re-emergence of measles outbreaks.


"The number of reported measles cases declined dramatically after the
successful 2003 campaign," says Angela Kearney, a representative of UNICEF
Angola, "but routine coverage still requires strengthening in many
provinces."


Drawing on the successful experience in 2003, additional life-saving
health interventions will be integrated into the upcoming measles campaign.
Approximately 800,000 insecticide treated nets will be distributed across
seven provinces where malaria transmission rates are highest. Insecticide
treated nets are proven to be one of the most effective methods for
preventing malaria, a leading cause of death and disability for children in
Angola. Children under age five will also receive polio vaccinations,
vitamin A and de-worming medication.


The integrated campaign will be carried out with support from the
Measles Initiative, a partnership formed to reduce measles deaths in
sub-Saharan Africa that is led by the American Red Cross, United Nations
Foundation, World Health Organization (WHO), United Nations Children's Fund
(UNICEF) and U.S. Centers for Disease Control and Prevention (CDC).


Additional supporters in this campaign include: USAID, the U.S.
President's Malaria Initiative, the Global Fund, CORE, the governments of
Japan and Norway, CIDA, Rotary International and DFID. ExxonMobil
contributed financial resources and will provide approximately 70,000
LLIN's to protect children against malaria.


Since 2001, the Measles Initiative has vaccinated more than 213 million
children in more than 40 African countries, saving approximately 1.2
million lives. Through the financial and technical support of the Measles
Initiative and the commitment of African governments, measles deaths in
Africa have fallen 60 percent between 1999 and 2004. This decline
represents significant progress toward the overall goal of reducing measles
deaths worldwide by 90 percent by 2010.


Background:


The Measles Initiative, launched in 2001, is a long-term commitment and
partnership among leaders in public health and supports the goal of
reducing measles deaths globally by 90 percent by 2010 compared to 2000.
Measles Initiative partners include the American Red Cross, United Nations
Foundation, CDC, WHO and UNICEF.


Largely due to the technical and financial support of the Measles
Initiative and the commitment from African governments, more than 200
million children have been vaccinated against measles and an estimated 1.2
million lives have been saved since 2001. Building on this achievement, in
2005, the Initiative has expanded its technical and financial support to
countries in Asia, where total measles deaths are highest outside of
sub-Saharan Africa.


The Initiative will also continue to carry out integrated campaigns in
which health workers provide not only measles vaccines, but also other
interventions such as insecticide-treated nets for malaria prevention,
vitamin A, de-worming medication and polio vaccines.


Since 2001, the Measles Initiative has mobilized more than $200 million
and supported more than 40 African countries and three Asian countries to
implement high-quality measles vaccination campaigns. As a result of these
campaigns, as well as improvements in routine immunization activities,
global measles deaths have dropped by 48 percent from 871,000 in 1999 to an
estimated 454,000 in 2004. The largest reduction occurred in Africa, the
region with the highest burden of disease, where estimated measles cases
and deaths dropped by 60 percent.


Supporters of the Measles Initiative also include: the Global Alliance
for Vaccines and Immunization (GAVI Alliance), The Bill and Melinda Gates
Foundation, Vodafone Group Foundation, Canadian International Development
Agency (CIDA), Japanese International Agency for Cooperation (JICA),
Department for International Development of the United Kingdom (DFID),
International Federation of Red Cross and Red Crescent Societies
(Federation), the Church of Jesus Christ of Latter-Day Saints, Izumi
Foundation, Becton, Dickinson and Company, and governments.


Measles is one of the leading vaccine-preventable childhood killers in
the world. In 2004, it was estimated that there were 454,000 measles deaths
globally -- this translates to more than 1,200 deaths every day or 50 every
hour. The overwhelming majority of these deaths, that is 410,000 out of
454,000, are children under the age of five.


A safe and highly effective vaccine has been available for more than 40
years and costs less than US $1, making measles vaccinations one of the
most cost-effective public health interventions available for preventing
deaths. Despite this, millions of children remain at risk.


For more information about the Measles Initiative, log on to
measlesinitiative. To make a financial contribution, call
1-800 RED CROSS or to make a secure online donation, log on to
measlesinitiative.


American Red Cross

measlesinitiative

Buy Amikacin Without Prescription